Two Sigma Advisers’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-12,719
| Closed | -$17.9K | – | 2616 |
|
|
2023
Q2 | $17.9K | Sell |
12,719
-3,000
| -19% | -$4.23K | ﹤0.01% | 2327 |
|
|
2023
Q1 | $25K | Sell |
15,719
-25,300
| -62% | -$40.2K | ﹤0.01% | 2508 |
|
|
2022
Q4 | $59.9K | Buy |
41,019
+29,919
| +270% | +$43.7K | ﹤0.01% | 2346 |
|
|
2022
Q3 | $47K | Sell |
11,100
-1,900
| -15% | -$8.05K | ﹤0.01% | 2378 |
|
|
2022
Q2 | $50K | Sell |
13,000
-4,418
| -25% | -$17K | ﹤0.01% | 2482 |
|
|
2022
Q1 | $83K | Sell |
17,418
-30,726
| -64% | -$146K | ﹤0.01% | 2531 |
|
|
2021
Q4 | $176K | Buy |
+48,144
| New | +$176K | ﹤0.01% | 2312 |
|
|
2020
Q3 | – | Sell |
-321
| Closed | -$3K | – | 2668 |
|
|
2020
Q2 | $3K | Sell |
321
-243
| -43% | -$2.27K | ﹤0.01% | 2474 |
|
|
2020
Q1 | $8K | Sell |
564
-2,028
| -78% | -$28.8K | ﹤0.01% | 2430 |
|
|
2019
Q4 | $31K | Buy |
2,592
+2,060
| +387% | +$24.6K | ﹤0.01% | 2308 |
|
|
2019
Q3 | $13K | Sell |
532
-169
| -24% | -$4.13K | ﹤0.01% | 2190 |
|
|
2019
Q2 | $18K | Buy |
701
+237
| +51% | +$6.09K | ﹤0.01% | 2281 |
|
|
2019
Q1 | $20K | Sell |
464
-20
| -4% | -$862 | ﹤0.01% | 2256 |
|
|
2018
Q4 | $7K | Sell |
484
-89
| -16% | -$1.29K | ﹤0.01% | 2328 |
|
|
2018
Q3 | $40K | Buy |
573
+17
| +3% | +$1.19K | ﹤0.01% | 2187 |
|
|
2018
Q2 | $41K | Buy |
+556
| New | +$41K | ﹤0.01% | 2311 |
|
|
2015
Q1 | – | Sell |
-170
| Closed | -$91K | – | 2227 |
|
|
2014
Q4 | $91K | Sell |
170
-170
| -50% | -$91K | ﹤0.01% | 2017 |
|
|
2014
Q3 | $509K | Buy |
+340
| New | +$509K | ﹤0.01% | 1195 |
|